ZYVERSA THERAPEUTICS INC (ZVSA) Stock Price, Quote & AI Analysis

Live ZVSA stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for ZYVERSA THERAPEUTICS INC.

TradeVae provides AI-driven analysis and real-time market intelligence for ZYVERSA THERAPEUTICS INC (ZVSA), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

Z
ZVSA
ZYVERSA THERAPEUTICS INC
real-time
$0.00 +0.00 (+0.00%)
Open
0.190000
High
0.228400
Low
0.190000
Volume
29,654
VWAP
-
52W Range
$0.19 - $523.25
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
May 11, 2026 Q1
Market
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

ZYVERSA THERAPEUTICS INC's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

ZYVERSA THERAPEUTICS INC Overview

Company information

Company Overview

ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It leverages advanced & proprietary technologies to develop product candidates in the areas of renal and inflammatory diseases. The company was founded by Stephen C. Glover in 2014 and is headquartered in Weston, FL.

Company Details
Market Cap
$8.72M
Shares Outstanding
43,515,401
CEO
Stephen C. Glover
Exchange
OTC Link

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

ZYVERSA THERAPEUTICS INC Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...